Hannah Spaepen is Global Head of CMC Portfolio Management at Thermo Fisher Scientific Pharma Services, leading the commercial CMC organization globally and shaping strategic partnerships with biotech and biopharma companies across the drug development lifecycle. With 25+ years of international executive experience spanning pharmaceutical R&D, supply chain, global CDMO operations, M&A, and business leadership, Hannah brings a distinctive end-to-end perspective on the opportunities and risks of increasingly integrated CDMO partnerships. Having led complex global organizations and manufacturing networks, she combines strategic, commercial, and operational perspectives to help companies balance speed, resilience, flexibility, and long-term value in an increasingly complex biopharma ecosystem.